SCHEMBL6068053

SCHEMBL6068053

COc1cccc(-c2cc(O)cc(O)c2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 5/20 0.62
ABCB1 P08183 5/20 0.62
BCR P11274 5/20 0.62
NPC1 O15118 1/20 0.62
TP53 P04637 1/20 0.62
MAPK1 P28482 1/20 0.62
CASP3 P42574 1/20 0.62
RAB9A P51151 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
SENP8 Q96LD8 1/20 0.62
SENP7 Q9BQF6 1/20 0.62
SENP6 Q9GZR1 1/20 0.62
CYP1A1 P04798 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2E1 P05181 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2C8 P10632 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2A6 P11509 1/20 0.61
CYP2C9 P11712 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1027189 0.90 HDAC4 (0.62) ABL1ABCB1BCRCYP1A1CYP1A2
SCHEMBL196765 0.85 CYP3A4 (0.73) ABL1ABCB1BCRCYP1A1CYP1A2
SCHEMBL29489425 0.85 CYP3A4 (0.73) ABL1ABCB1BCRCYP1A1CYP1A2
SCHEMBL24177866 0.84 ABL1 (0.79) ABL1ABCB1BCRCYP1A1CYP1A2
SCHEMBL21296972 0.84 ABL1 (0.73) ABL1ABCB1BCRNPC1TP53
SCHEMBL1513611 0.84 ABL1 (0.79) ABL1ABCB1BCRCYP1A1CYP1A2
SCHEMBL5620245 0.83 CYP3A4 (0.86) ABL1ABCB1BCRCYP1A1CYP1A2
SCHEMBL29628977 0.83 CYP3A4 (0.77) ABL1ABCB1BCRCYP1A1CYP1A2
Hydrogen Sulfide SCHEMBL28640169 0.83 CYP3A4 (0.70) ABL1ABCB1BCRCYP1A1CYP1A2
Ammonia Solution, Strong SCHEMBL27960505 0.83 CYP3A4 (0.70) ABL1ABCB1BCRCYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
EP-1392673-A2 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2004-03-03 EP disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed
WO-2002096901-A2 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2002-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 ABL1 2506/4885ABCB1 860/4885BCR 1896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.